Company Filing History:
Years Active: 2007
Title: Eyal Gruebaum: Innovator in Immune System Modulation
Introduction
Eyal Gruebaum is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in the modulation of the immune system, particularly through the manipulation of specific receptors.
Latest Patents
Eyal Gruebaum holds a patent titled "Methods of modulation of the immune system." This patent focuses on the manipulation of the EphB6 receptor and its active Eph partners, which allows for the regulation of T cell responses. The patent details methods for modulating EphB6, including various therapeutic applications that can impact T cell receptor signaling, T cell proliferation, and the induction of T cell death.
Career Highlights
Eyal Gruebaum is affiliated with The Hospital for Sick Children, where he conducts his research. His work has been instrumental in advancing the understanding of immune system modulation and its potential therapeutic applications.
Collaborations
Eyal has collaborated with esteemed colleagues such as Chaim M Roifman and Andrew Freywald, contributing to a rich environment of innovation and research.
Conclusion
Eyal Gruebaum's contributions to immunology through his patent and research at The Hospital for Sick Children highlight his role as a key innovator in the field. His work continues to pave the way for advancements in immune system therapies.